Use of Topical Timolol Maleate as Re-Epithelialization Agent for Treatment of Recalcitrant Wounds of Varying Etiologies

Brian A. Cahn, Ramanjot Kaur, Penelope A. Hirt, Catherine Tchanque-Fossuo, Sara E. Dahle, Robert S. Kirsner, Roslyn Rivkah Isseroff, Hadar Lev-Tov

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Chronic wounds are a source of severe morbidity to patients.1 Wounds are also a notable burden on the healthcare system, with reported prevalence of 4.64% in the U.S. and an annual cost of over 25 billion dollars.2,3 Moreover, wounds are associated with >15% of all skin disease-related deaths4 and the 5 year mortality of some chronic wounds is greater than that of many cancers.5.

Original languageEnglish (US)
Pages (from-to)1252-1256
Number of pages5
JournalJournal of drugs in dermatology : JDD
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2020

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Use of Topical Timolol Maleate as Re-Epithelialization Agent for Treatment of Recalcitrant Wounds of Varying Etiologies'. Together they form a unique fingerprint.

Cite this